Dr. Carson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2160 S. First Avenue
EMS 110 Room 3274
Maywood, IL 60153Phone+1 708-327-2680Fax+1 708-327-3474
Summary
- Josh Carson is an academic burn surgeon, with a commitment to treating patients with burns and other major wounds along the entire continuum of care-- from resuscitation, to rehabilitation and reconstruction. His principle research interests include emerging burn care technology and clinical trials, mass casualty preparedness, and management of burn pain and psychiatric response to trauma. He is an active in
Dr. Carson is the Medical Director at the Burn Center at Loyola University Medical center. serves the Chicagoland Area, the State of Illinois and the broader Midwestern United States. He is also the chief medical officer of the Illinois State Burn Coordinating Center.
Education & Training
- University of Texas Medical Branch HospitalsFellowship, Surgical Critical Care, 2014 - 2016
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 2011 - 2014
- New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2007 - 2009
- Weill Cornell MedicineClass of 2007
- Harvard UniversityBA, Cum Laude, English and American Literature and Language, 1998 - 2002
- University of Texas Medical Branch HospitalsFellowship, Burn Surgery
Certifications & Licensure
- CA State Medical License 2011 - Present
- IL State Medical License 2021 - 2026
- FL State Medical License 2016 - 2022
- NY State Medical License 2010 - 2011
- American Board of Surgery Surgery
- American Board of Surgery Surgical Critical Care
- AOA Board of Surgery Surgical Critical Care (CAQ)
Clinical Trials
- Evaluating MMPs in Burns Start of enrollment: 2017 Jun 09
- CellMist™ Autologous Cells to Treat Deep Second-Degree Burns Start of enrollment: 2021 May 26
- Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 19 citationsIrreversible electroporation is a surgical ablation technique that enhances gene transferJoyce T. Au, Joyce Wong, Arjun Mittra, Susanne G. Carpenter, Dana Haddad
Surgery. 2011-09-01 - 15 citationsIrreversible electroporation facilitates gene transfer of a GM-CSF plasmid with a local and systemic response.Joyce T. Au, Arjun Mittra, Tae Jin Song, Michael J. Cavnar, Kyonghwa Jun
Surgery. 2013-09-01 - 33 citationsTunneling nanotubes: an alternate route for propagation of the bystander effect following oncolytic viral infection.Justin W. Ady, Venugopal Thayanithy, Kelly Mojica, Phillip Wong, Joshua Carson
Molecular Therapy Oncolytics. 2016-01-01
Journal Articles
- Imaging Characteristics, Tissue Distribution, and Spread of a Novel Oncolytic Vaccinia Virus Carrying the Human Sodium Iodide SymporterHaddad D, Chen CH, Carlin S, Silberhumer G, Chen NG, Zhang Q, Longo V, Carpenter SG, Mittra A, Carson, Au J, Gonen M, Zanzonico PB, Szalay AA, Fong Y, PLoS One, 1/1/2012
- Spray Cryotherapy Is Effective for Bronchoscopic, Endoscopic, and Open Ablation of Thoracic TissuesAu JT, Carson J, Monette S, Finley DJ, Interact Cardiovasc Thorac Surg, 1/1/2012
- Flexible CO2 Laser and Submocosal Gel Injection for Safe Endoluminal Resection in the IntestinesAu JT, Mittra A, Wong J, Carpenter S, Carson J, Haddad D, Monette S, Ezell P, Patel S, Fong Y, Surg Endosc, 1/1/2012
- Join now to see all
Abstracts/Posters
- Toxic Epidermal Necrolysis: A 30 Year Institutional ExperienceCarson J, Crites N, Grogans RA, Capek KD, Finnerty C, Lee JO, Herndon DN, American Burn Association 47th Annual Meeting in Chicago, 1/23/2015
- Structural and Functional Changes in Pediatric Burn Victims Two Years after InjuryCarson J, Jeschke MG, Mlcak R, Herndon DN, Suman O, American Burn Association 47th Annual Meeting in Chicago, 1/23/2015
Lectures
- hNIS Expressing Oncolytic Virus GLV-1h153 is a Promising Agent for the Imaging and Treatment of Non-Small Cell Lung Cancer1/1/2011
- Lung Cancer Tumor-initiating Cells Overexpress GADD34 and Are Sensitive to Viral Oncolysis1/1/2011
- Blockade of Beta-adrenergic Signaling Does Not Influence Fracture Healing in a Mouse ModelSan Francisco - 1/1/2008
- Join now to see all
Press Mentions
- Loyola Chicago Doctors Treat Severe Child Burn Victims with New TechnologyApril 18th, 2024
Professional Memberships
- American Burn AssociationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: